NEWRegulation

Xenon Pharmaceuticals Inc. (XENE) Files DEF 14A on April 22

Published on 4/22/2026

#XENE#SEC#filing#shareholders
Xenon Pharmaceuticals Inc. (XENE) Files DEF 14A on April 22

AI Summary

Xenon Pharmaceuticals Inc. (XENE) submitted its DEF 14A filing on April 22. This document includes important shareholder information and is a required filing for upcoming meetings. Specific details regarding executive compensation, board nominees, and shareholder proposals are typically outlined in such filings. The filing ensures compliance with SEC regulations and aids in transparency for investors.

Source: Read original article (opens in new tab)

Related News

US Senate Plans ICE Funding Amidst Voting Session
Regulation

US Senate Plans ICE Funding Amidst Voting Session

Apr 22

HIPPO HOLDINGS INC. (HIPO) Files DEF 14A for April 22 Meeting
Corporate Governance

HIPPO HOLDINGS INC. (HIPO) Files DEF 14A for April 22 Meeting

Apr 22

Hasbro (HAS) DEF 14A Filing Details Released for April 22
Regulation

Hasbro (HAS) DEF 14A Filing Details Released for April 22

Apr 22

AN2 Therapeutics (ANTX) Issues DEF 14A Filing for April 22 Meeting
Regulation

AN2 Therapeutics (ANTX) Issues DEF 14A Filing for April 22 Meeting

Apr 22